HillSignal

TICKER INTELLIGENCE

Tandem Diabetes Care, Inc. ($TNDM)

$20.11 13.2% (7d)

NYSE/NASDAQ: TNDM

Washington Intelligence

1

Active Bills

0

Gov't Contracts

9

Congressional Trades

$TNDM is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 1 active Congressional signal mentioning $TNDM, including 1 bill. The legislative sentiment is currently mixed, with both supportive and challenging policy signals in play.

Congressional Trades in $TNDM

9 filings
Josh Gottheimer
BUY $1,001 - $15,000 — Tandem Diabetes Care Inc

System: No suspicious timing patterns detected

2025-10-16
1 flag
Josh GottheimerD-NJ
BUY $1,001 - $15,000 — Tandem Diabetes Care, Inc. - Common Stock

Rep. Gottheimer bought $1,001 - $15,000 in TNDM on September 22, 2025 — 4 days before HR5605, the Medical Device Nonvisual Accessibility Act of 2025, was introduced.

2025-10-15
2 flags
Josh Gottheimer
SELL $1,001 - $15,000 — Tandem Diabetes Care Inc

System: No suspicious timing patterns detected

2025-04-11
1 flag
Josh GottheimerD-NJ
SELL $1,001 - $15,000 — Tandem Diabetes Care, Inc. - Common Stock (TNDM)

Rep. Gottheimer sold $1,001 - $15,000 in DHI on 2025-03-19 — 8 days before the 'Revitalizing Downtowns and Main Streets Act' (HR2410) was introduced, a bill proposing an investment tax credit for converting non-residential buildings.

2025-04-10
5 flags
Gilbert CisnerosD-CA
BUY $1,001 - $15,000 — Tandem Diabetes Care, Inc. - Common Stock (TNDM) [ST]

Gilbert Cisneros bought $1,001 - $15,000 in BA (Boeing Company) on March 31, 2025 — 1 day before HR2559, the "Taiwan Allies Fund Act," was introduced, which could impact defense contractors.

2025-04-07
5 flags
Josh GottheimerD-NJ
BUY $1,001 - $15,000 — Tandem Diabetes Care, Inc. - Common Stock

Rep. Gottheimer bought and sold $15K-$50K in MSFT on August 12, 2024 — 14 days before Deloitte & Touche secured a $66.8M VA cybersecurity contract. While Microsoft is not the direct contractor, the timing of both a buy and sell before a neutral-signal award is unusual.

2024-09-11
1 flag
Daniel GoldmanD-NY
SELL $1,001 - $15,000 — Tandem Diabetes Care Inc

System: No suspicious timing patterns detected

2023-08-13
1 flag
Ro Khanna
SELL $1,001 - $15,000 — Tandem Diabetes Care Inc

System: No suspicious timing patterns detected

2022-09-08
1 flag
Ro Khanna
BUY $1,001 - $15,000 — Tandem Diabetes Care Inc

System: No suspicious timing patterns detected

2022-06-10
1 flag

Related Sectors

Congressional Legislation Affecting Tandem Diabetes Care, Inc. ($TNDM)

HR5605, the Medical Device Nonvisual Accessibility Act, is in early committee stage with zero appropriation — a compliance mandate, not a spending bill. Home medical device makers face moderate retrofit costs but no immediate revenue impact. Market data shows medtech stocks already under broad 30-day pressure (-8% to -11%), and this bill adds a minor regulatory cost layer without near-term catalyst.

Same as above — compliance costs for redesign or retrofit of digital interfaces for nonvisual accessibility.

HR5605

Understanding These Signals

Get Full Access to Tandem Diabetes Care, Inc. ($TNDM) Signals

Daily AI-analyzed alerts for Congressional activity affecting your portfolio.

Get Started →